Tobacco Dependence — MCQs
In which of the following conditions is behavioral therapy most commonly utilized?
Which of the following drugs is used for smoking cessation?
Mechanism of action of d-tubocurarine is:
A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. What is the reason behind this condition?
After a thorough study of socio-demographic characteristics of a population in Dhok Ratta, a relevant method of health education against smoking was employed to this population. Upon assessing the population habits even after lapse of 2 years, no change in the behaviour of the smokers was noted. What is likely to be missing in this programme to achieve the desired results?
A chronic smoker wants to quit smoking. Which of the following is the MOST appropriate first-line pharmacotherapy for smoking cessation?
Which components of cigarette smoke are known to contribute to coronary artery disease?
A 45 year old male with a history of alcohol dependence presents with confusion, nystagmus and ataxia. Examination reveals 6th cranial nerve weakness. He is most likely to be suffering from:
A 48-year-old female presents to your office with a 1-year history of dry eyes and difficulty swallowing. She complains of blinking frequently and of eye strain while using her computer at work. She also reports stiffness in her knees and lower back. Past medical history is unremarkable and she does not take medications. She denies cigarette or alcohol use. Family history is notable for Hashimoto's thyroiditis in her mother. Physical exam shows dry oral mucosa and enlargement of the parotid glands. Which of the following serologies is likely to be positive in this patient?
What are nitrergic neurons?
Tobacco Dependence Indian Medical PG Practice Questions and MCQs
Question 1: In which of the following conditions is behavioral therapy most commonly utilized?
- A. Schizophrenia
- B. Agoraphobia (Correct Answer)
- C. Delirium
- D. Neurotic depression
Explanation: ***Agoraphobia*** - **Behavioral therapy**, particularly **exposure therapy**, is the **gold standard and first-line treatment** for agoraphobia. - It involves **systematic desensitization** and gradual exposure to feared situations (e.g., crowded places, public transport, open spaces). - This approach directly reduces **avoidance behaviors** and anxiety responses, making it the most commonly utilized behavioral intervention among these conditions. *Schizophrenia* - While behavioral interventions can be part of a comprehensive treatment plan, **pharmacotherapy** (antipsychotics) is the cornerstone for managing positive and negative symptoms. - Behavioral approaches often focus on **social skills training** and vocational rehabilitation, not primary symptom reduction. *Delirium* - The primary management for delirium involves identifying and treating the **underlying medical cause** and providing supportive care. - Behavioral therapy is generally not indicated as this condition is an **acute organic brain syndrome** requiring medical management. *Neurotic depression* - This term is largely outdated; current diagnostic manuals use terms like **persistent depressive disorder (dysthymia)** or **major depressive disorder**. - While behavioral activation is a component of CBT for depression, the primary treatments are **cognitive behavioral therapy (CBT)** and/or **pharmacotherapy** (antidepressants), rather than purely behavioral therapy.
Question 2: Which of the following drugs is used for smoking cessation?
- A. Gabapentin
- B. Acamprosate
- C. Nalmefene
- D. Varenicline (Correct Answer)
Explanation: ***Varenicline*** - **Varenicline** is a **partial agonist** at the **α4β2 nicotinic acetylcholine receptor**, reducing cravings and withdrawal symptoms while decreasing the rewarding effects of nicotine [2]. - It is a first-line pharmacotherapy for **smoking cessation**, often initiated a week before the target quit date. *Gabapentin* - **Gabapentin** is primarily an **anticonvulsant** and is also used to treat **neuropathic pain**. - It is not indicated for **smoking cessation** and acts by modulating **GABAergic neurotransmission**, unrelated to nicotine dependence. *Acamprosate* - **Acamprosate** is used to maintain **abstinence from alcohol** in patients with alcohol dependence. - Its mechanism involves restoring the balance between **excitation and inhibition** in the brain, which is not directly applicable to nicotine dependence. *Nalmefene* - **Nalmefene** is an **opioid system modulator** used for reducing **alcohol consumption** in adults with alcohol dependence [1]. - It acts as an **opioid receptor antagonist**, a mechanism distinct from the neurotransmitter systems involved in nicotine addiction [1].
Question 3: Mechanism of action of d-tubocurarine is:
- A. Competitive, nondepolarizing block at the Nm cholinergic receptor (Correct Answer)
- B. Noncompetitive, depolarizing block at the Nm cholinergic receptor
- C. Non-competitive, nondepolarizing block at the Nm cholinergic receptor
- D. Competitive, depolarizing block at the Nm cholinergic receptor
Explanation: ***Competitive, nondepolarizing block at the Nm cholinergic receptor*** - **d-tubocurarine** acts as a **competitive antagonist** at the **nicotinic muscle (Nm) cholinergic receptors** on the motor endplate. - It competes with **acetylcholine (ACh)** for binding sites, preventing ACh from activating the receptor and causing **muscle paralysis** without depolarization. *Noncompetitive, depolarizing block at the Nm cholinergic receptor* - This describes the mechanism of action of **depolarizing neuromuscular blockers** like **succinylcholine**, which first *depolarize* the motor endplate before causing paralysis. - d-tubocurarine does not cause initial depolarization; it directly blocks the receptor. *Non-competitive, nondepolarizing block at the Nm cholinergic receptor* - While d-tubocurarine is **nondepolarizing**, it is a **competitive antagonist**, not a non-competitive one. - A non-competitive block would involve binding to a different site on the receptor or an associated ion channel, altering receptor function indirectly. *Competitive, depolarizing block at the Nm cholinergic receptor* - This option incorrectly combines the concepts, as **depolarizing blockers** like succinylcholine act initially by **depolarizing** the endplate, whereas d-tubocurarine is purely a **nondepolarizing** agent. - The "competitive" aspect would be true for the binding of ACh to its site on a depolarizing agent, but the effect of d-tubocurarine is simply to block, not depolarize.
Question 4: A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. What is the reason behind this condition?
- A. Postural hypotension
- B. Receptor upregulation
- C. Rebound hypertension (Correct Answer)
- D. Receptor hypersensitivity
Explanation: ***Rebound hypertension*** - **Clonidine withdrawal** can cause a sudden surge in blood pressure due to increased sympathetic activity, leading to **rebound hypertension** and symptoms like headaches. - This occurs because chronic clonidine use suppresses sympathetic outflow, and its abrupt discontinuation unmasks this suppressed activity, causing a hypertensive crisis. *Postural hypotension* - **Postural hypotension** is a common side effect of clonidine due to its vasodilatory effects, causing blood pressure to drop when standing. - However, the patient's headache following clonidine cessation is more indicative of a **hypertensive event**, not hypotension. *Receptor upregulation* - **Receptor upregulation** refers to an increase in the number of receptors, often in response to prolonged antagonism or decreased ligand exposure. - While receptor changes occur, the primary mechanism of clonidine withdrawal is the **overcompensation** of the sympathetic nervous system, not simply an increased number of receptors. *Receptor hypersensitivity* - **Receptor hypersensitivity** implies an exaggerated response to a normal concentration of a neurotransmitter, which can contribute to withdrawal symptoms. - While it plays a role, the more immediate and critical cause of the headache is the rapid increase in blood pressure due to **rebound sympathetic activity**.
Question 5: After a thorough study of socio-demographic characteristics of a population in Dhok Ratta, a relevant method of health education against smoking was employed to this population. Upon assessing the population habits even after lapse of 2 years, no change in the behaviour of the smokers was noted. What is likely to be missing in this programme to achieve the desired results?
- A. Knowledge of beliefs
- B. Knowledge of cultures
- C. Reinforcement (Correct Answer)
- D. Required devotion
Explanation: ***Reinforcement*** - **Reinforcement** is crucial for sustaining behavior change over time, especially for habits like smoking. Without continued support and reminders, initial educational efforts often fade. - The lack of change after two years, despite an initial "relevant method of health education," suggests that the initial intervention was not adequately reinforced to maintain its impact. *Knowledge of beliefs* - While understanding **beliefs** is vital for tailoring health education messages, the question states that "a relevant method of health education" was employed after "thorough study of socio-demographic characteristics." This implies beliefs were likely considered in the initial program design. - If the initial program was relevant, it means it probably addressed existing beliefs, but the long-term sustainability was lacking. *Knowledge of cultures* - Similar to beliefs, **cultural understanding** is fundamental for designing effective and relevant health education. The phrase "thorough study of socio-demographic characteristics" suggests that cultural aspects would have been assessed during the program's initial planning. - If the program was initially deemed "relevant," it implies cultural factors were likely addressed, but their ongoing influence requires reinforcement. *Required devotion* - **Devotion**, while important for program implementers, refers more to the commitment of the people running the program rather than a specific component of the health education strategy itself that would directly impact sustained behavior change in the population. - This option is broader and less specific to the programmatic elements that ensure lasting health behavior modification compared to reinforcement.
Question 6: A chronic smoker wants to quit smoking. Which of the following is the MOST appropriate first-line pharmacotherapy for smoking cessation?
- A. Mirtazapine
- B. Varenicline (Correct Answer)
- C. Bupropion
- D. Nicotine replacement therapy
- E. Clonidine
Explanation: ***Varenicline*** - **Varenicline** is a **partial agonist** at the **α4β2 nicotinic acetylcholine receptor**, the primary receptor involved in nicotine addiction. - It reduces cravings and withdrawal symptoms while blocking the reinforcing effects of nicotine from cigarettes. - Studies show **varenicline has the highest efficacy** among pharmacological agents for smoking cessation, with superior quit rates compared to bupropion and NRT. - **First-line agent** recommended by clinical guidelines for smoking cessation. *Mirtazapine* - Mirtazapine is a **tetracyclic antidepressant** (α2-antagonist, 5-HT2 and 5-HT3 antagonist) used for **major depressive disorder**. - **Not indicated** for smoking cessation and lacks evidence for efficacy in this context. - May cause weight gain and sedation, which are not beneficial for smoking cessation. *Bupropion* - **Bupropion** is an **atypical antidepressant** and **norepinephrine-dopamine reuptake inhibitor (NDRI)** that also antagonizes nicotinic receptors. - Effective **first-line agent** for smoking cessation, reducing cravings and withdrawal symptoms. - However, studies show **lower efficacy compared to varenicline** in head-to-head trials. - Contraindicated in patients with seizure disorders or eating disorders. *Nicotine replacement therapy* - **NRT** (patches, gum, lozenges, inhalers, nasal spray) provides controlled nicotine delivery without harmful tobacco combustion products. - Effective **first-line therapy** that reduces withdrawal symptoms and cravings. - Generally **less effective than varenicline** when used alone, but can be combined with other therapies. - Safest option with minimal contraindications. *Clonidine* - **Clonidine** is a **central α2-agonist** primarily used for hypertension. - Considered a **second-line agent** for smoking cessation, used only when first-line therapies fail or are contraindicated. - Less effective than first-line agents and associated with more adverse effects (sedation, dry mouth, hypotension). - Not routinely recommended for smoking cessation.
Question 7: Which components of cigarette smoke are known to contribute to coronary artery disease?
- A. Nicotine, carbon monoxide, and tar (Correct Answer)
- B. Carbon monoxide and tar
- C. Carbon dioxide
- D. Tar and nicotine
Explanation: ***Nicotine, carbon monoxide, and tar*** - **Nicotine** directly affects the cardiovascular system by increasing **heart rate**, **blood pressure**, and causing **vasoconstriction**, as well as promoting atherogenesis [2]. - **Carbon monoxide** binds to hemoglobin with higher affinity than oxygen, forming **carboxyhemoglobin**, which reduces oxygen delivery to tissues, leading to **endothelial damage** and contributing to atherosclerosis [1]. - **Tar** contains various **carcinogens** and toxic chemicals that contribute to inflammation, oxidative stress, and lipid peroxidation, all of which are implicated in the development and progression of **atherosclerosis**. *Carbon monoxide and tar* - While both contribute significantly, this option **omits nicotine**, which is a major contributor to the cardiovascular effects of smoking. - Nicotine's direct impact on **vasoconstriction** and **atherogenesis** is a critical factor in coronary artery disease [2]. *Carbon dioxide* - **Carbon dioxide** is a product of respiration and combustion but is not considered a primary direct contributor to the pathogenesis of **coronary artery disease** from cigarette smoke in the same way as nicotine, carbon monoxide, and tar. - Its presence in smoke primarily relates to its role in **respiratory physiology** rather than direct vascular damage. *Tar and nicotine* - This option correctly identifies **tar** and **nicotine** as contributors but **omits carbon monoxide**, which plays a crucial role in reducing oxygen-carrying capacity and directly damaging the endothelium [1]. - The impact of **carbon monoxide** on cardiac oxygen supply is a significant mechanism in smoking-related cardiovascular disease [1].
Question 8: A 45 year old male with a history of alcohol dependence presents with confusion, nystagmus and ataxia. Examination reveals 6th cranial nerve weakness. He is most likely to be suffering from:
- A. Wernicke encephalopathy (Correct Answer)
- B. De Clerambault syndrome
- C. Korsakoff's psychosis
- D. Delirium tremens
Explanation: ***Wernicke encephalopathy*** - The classic triad of **confusion**, **nystagmus**, and **ataxia** in a patient with alcohol dependence is highly indicative of Wernicke encephalopathy [1], [2]. - The presence of **6th cranial nerve weakness (abducens palsy)** further supports this diagnosis, as ocular abnormalities are common [2]. *De Clérambault syndrome* - This is a delusional disorder where an individual believes another person, often of higher social status, is in love with them (also known as **erotomania**). - It is a psychiatric condition and does not present with neurological signs like ataxia, nystagmus, or cranial nerve palsies. *Korsakoff's psychosis* - While also associated with chronic alcohol abuse and often follows Wernicke encephalopathy, Korsakoff's psychosis is characterized primarily by **severe memory impairment (anterograde and retrograde amnesia)**, confabulation, and lack of insight [2]. - The acute presentation with confusion, nystagmus, and ataxia is more characteristic of Wernicke encephalopathy, which can progress to Korsakoff's if untreated [2]. *Delirium tremens* - This is a severe form of **alcohol withdrawal** characterized by profound confusion, agitation, disorientation, **hallucinations**, tachycardia, hypertension, and seizures [1]. - While confusion is present, the specific neurological signs of nystagmus, ataxia, and cranial nerve weakness are not typical features like they are in Wernicke encephalopathy.
Question 9: A 48-year-old female presents to your office with a 1-year history of dry eyes and difficulty swallowing. She complains of blinking frequently and of eye strain while using her computer at work. She also reports stiffness in her knees and lower back. Past medical history is unremarkable and she does not take medications. She denies cigarette or alcohol use. Family history is notable for Hashimoto's thyroiditis in her mother. Physical exam shows dry oral mucosa and enlargement of the parotid glands. Which of the following serologies is likely to be positive in this patient?
- A. Anti-Jo-1
- B. Anti-dsDNA
- C. Anti-SS-A (Correct Answer)
- D. Anti-Smith
- E. Anti-CCP
Explanation: ***Anti-SS-A*** * This patient's symptoms of **dry eyes**, **difficulty swallowing**, **dry oral mucosa**, and **enlarged parotid glands** are highly indicative of **Sjögren's syndrome** [1]. * **Anti-SS-A (Ro)** antibodies are present in 60-70% of patients with primary Sjögren's syndrome and are recognized as a diagnostic marker [1]. * *Anti-Jo-1* * **Anti-Jo-1** antibodies are primarily associated with **polymyositis** and **dermatomyositis**, particularly the anti-synthetase syndrome, characterized by muscle weakness and interstitial lung disease, which are not described in this patient. * The patient's symptoms are focused on sicca manifestations rather than muscle inflammation. * *Anti-dsDNA* * **Anti-dsDNA** antibodies are highly specific for **Systemic Lupus Erythematosus (SLE)** and are often associated with lupus nephritis. * The patient presents with symptoms more consistent with a primary sicca disorder rather than the multi-systemic involvement typical of SLE. * *Anti-Smith* * **Anti-Smith** antibodies are also highly specific for **Systemic Lupus Erythematosus (SLE)**, though less sensitive than anti-dsDNA [1]. * These antibodies are not typically found in Sjögren's syndrome without co-existing SLE. * *Anti-CCP* * **Anti-CCP (cyclic citrullinated peptide)** antibodies are highly specific for **rheumatoid arthritis** [2]. * While the patient reports knee and lower back stiffness, the primary complaints and physical findings point towards Sjögren's syndrome, not inflammatory arthritis.
Question 10: What are nitrergic neurons?
- A. Postganglionic neurons releasing nitric oxide.
- B. First-order neurons releasing nitric oxide. (Correct Answer)
- C. Postganglionic neurons releasing substance P.
- D. First-order neurons releasing calcitonin gene-related peptide.
Explanation: **Nitrergic neurons** are a specific class of neurons that utilize **Nitric Oxide (NO)** as their primary neurotransmitter. Unlike classical neurotransmitters stored in vesicles, NO is a gaseous molecule synthesized on demand by the enzyme **Neuronal Nitric Oxide Synthase (nNOS)** [1]. **Why Option B is Correct:** In the context of the autonomic and enteric nervous systems, nitrergic neurons are typically **first-order neurons** (primary neurons) that release NO to mediate physiological functions. In the gastrointestinal tract, they are the principal inhibitory neurons of the myenteric plexus, responsible for the relaxation of smooth muscles (e.g., the Lower Esophageal Sphincter and the Sphincter of Oddi) [2]. **Analysis of Incorrect Options:** * **Option A:** While some postganglionic parasympathetic fibers (like those in the corpora cavernosa) release NO, the term "nitrergic neuron" fundamentally refers to the primary/first-order signaling unit in the inhibitory pathways of the enteric nervous system. * **Option C & D:** Substance P and Calcitonin Gene-Related Peptide (CGRP) are neuropeptides associated with **peptidergic neurons**, primarily involved in pain transmission (nociception) and vasodilation, not nitrergic signaling [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia:** This condition results from the selective **loss of nitrergic neurons** in the myenteric (Auerbach's) plexus, leading to the failure of the Lower Esophageal Sphincter (LES) to relax. * **Erectile Dysfunction:** NO released from nitrergic nerves in the penis activates guanylyl cyclase, increasing cGMP and causing vasodilation [1]. Sildenafil works by preventing the breakdown of this cGMP. * **Infantile Hypertrophic Pyloric Stenosis:** Also associated with a deficiency of nNOS and nitrergic innervation at the pylorus.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free